An insightful article in Ophthalmology Times by Lejla Vajzovic, MD, FASRS, and Yesha Raval, explores the rapidly evolving landscape of ophthalmic clinical research.
As innovations in gene therapy, biologics, and drug-delivery systems reshape the field, clinical trials are becoming more complex and essential. The article highlights the rising demand for specialized care driven by an aging population, the growing role of CROs and SMOs in managing trials, and the need to preserve diversity and innovation in research sites. It also emphasizes the importance of collaboration across sponsors, CROs, SMOs, and independent investigators to sustain a robust and inclusive research ecosystem.